Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Affiliations
MSK Report News
Wednesday, March 03, 2010
Pain:
Patients Speak Out About the Pain of Fibromyalgia
Sometimes the best way to learn about a disease is to listen to the patients who suffer from it...
Thursday, February 25, 2010
Arthritis:
Physical Inactivity and Obesity Raises Arthritis Risk, Especially in Women
Arthritis rates are higher in the US than in Canada, according to a new study...
Wednesday, February 10, 2010
Imaging:
FDA Wants to Reduce Radiation Exposure from Medical Scans
Widespread use of CT scans and fluoroscopy is exposing some patients to unnecessary amounts of radiation, and raising their risk of cancer...
Tuesday, February 09, 2010
Procedures:
Minimally Invasive Hip Replacements Growing in Popularity
Orthopedic surgeons have developed techniques to make hip replacement operations less invasive, cutting down the length of time patients spend in the hospital and speeding up total recovery time...
Thursday, January 28, 2010
Pain:
Pain Pumps May Lead to Development of Chondrolysis
Hundreds of patients have developed the relatively rare ailment after the use of postsurgical pain pumps...
Wednesday, January 27, 2010
Arthritis:
RA Development Can Be Predicted by Inflammatory Cytokines
Increased concentrations of proinflammatory cytokines can predict onset of RA before symptoms develop...
Thursday, December 03, 2009
Weekly Roundup:
In the News This Week
Read what MSKreport has been tweeting about this week...
BioPharm Business News
Wednesday, February 17, 2010
AstraZeneca to Enter the RA Market
AstraZeneca is entering the rheumatoid arthritis (RA) market by gaining rights to Rigel’s RA drug...
Thursday, February 11, 2010
Merck Settles Vioxx Lawsuits
Merck & Co. has agreed to settle lawsuits over their withdrawn painkiller Vioxx with a strengthening of safety procedures, change of leadership, and payment of legal fees...
Tuesday, February 02, 2010
UCB to Exit the Primary Care Market in the US
Instead, the company plans to focus on becoming a patient-centric global biopharmaceutical leader...
Monday, February 01, 2010
CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response in Patients with Active Rheumatoid Arthritis
Pfizer’s oral JAK Inhibitor CP-690,550 shows efficacy at improving the pain, function, and health status of RA patients...
Tuesday, January 26, 2010
FDA Approves Tocilizumab for Refractory RA
Tocilizumab (Actemra) has been approved for adults with moderate-to-severe RA who have not achieved adequate response with other TNF therapies...
Wednesday, December 02, 2009
OxyPharma's New RA Drug Shows Positive Phase II Results
Rabeximod, an orally-administered DMARD, showed promise as a new RA treatment during a 16-week study...
